


Journal of International Oncology››2014,Vol. 41››Issue (8): 684-688.doi:10.3760/cma.j.issn.1673-422X.2014.09.013
Previous ArticlesNext Articles
Yu Fuhua, Jia Zhifan, Pu Peiyu, Wang Guangxiu, Zhang Anling, Yang Weidong
Online:2014-09-25Published:2014-09-05Contact:Yang Weidong E-mail: yangweidongshine@sina.comYu Fuhua, Jia Zhifan, Pu Peiyu, Wang Guangxiu, Zhang Anling, Yang Weidong. Inhibitory effect of knockingdown Yesassociated protein for the growth of SNB19 glioma cells[J]. Journal of International Oncology, 2014, 41(8): 684-688.
| [1] Pan D. The hippo signaling pathway in development and cancer[J]. Dev Cell, 2010, 19(4): 491-505. [2] Hong W, Guan KL. The YAP and TAZ transcription coactivators: key downstream effectors of the mammalian Hippo pathway[J]. Semin Cell Dev Biol, 2012, 23(7): 785-793. [3] Pan D.Hippo signaling in organ size control[J]. Genes Dev, 2007, 21(8): 886-897. [4] Zhao B, Lei QY, Guan KL. The HippoYAP pathway: new connections between regulation of organ size and cancer[J]. Curr Opin Cell Biol, 2008, 20(6): 638-646. [5] Xu MZ, Tao TJ, Lee NP, et al. Yesassociated protein is an independent prognostic marker in hepatocellular carcinoma[J]. Cancer, 2009, 115(19): 4576-4585. [6] Wang Y, Dong Q, Zhang Q, et al. Overexpression of yesassociated protein contributes to progression and poor prognosis of nonsmallcell lung cancer[J]. Cancer Sci, 2010, 101(5): 1279-1285. [7] Yuan M, Tomlinson V, Lara R, et al. Yesassociated protein (YAP) functions as a tumor suppressor in breast[J]. Cell Death Differ, 2008, 15(11): 1752-1759. [8] Zhang X, George J, Deb S, et al. The Hippo pathway transcriptional coactivator, YAP, is an ovarian cancer oncogene[J]. Oncogene, 2011, 30(25): 2810-2822. [9] Danovi SA, Rossi M, Gudmundsdottir K, et al. Yesassociated protein (YAP) is a critical mediator of cJundependent apoptosis[J]. Cell Death Differ, 2008, 15(1): 217-219. [10] Brent A, Bai H, Jain D, et al. Yesassociated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth[J]. J Neuropathol Exp Neurol, 2011, 70(7): 568-577. |
| [1] | Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei.Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction[J]. Journal of International Oncology, 2024, 51(4): 193-197. |
| [2] | Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan.Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity, proliferation, and apoptosis of multiple myeloma cells[J]. Journal of International Oncology, 2024, 51(3): 129-136. |
| [3] | Zhang Keping, Zhao Yongsheng, Yang Juan, Fu Maoyong.Chlorogenic acid induces mitochondrial dysfunction in lung cancer A549 cells by inhibiting the PI3K-Akt pathway[J]. Journal of International Oncology, 2024, 51(1): 21-28. |
| [4] | Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong.Effects of Anhydroicaritin on the proliferation, migration and apoptosis of hepatocellular carcinoma cells[J]. Journal of International Oncology, 2023, 50(9): 513-519. |
| [5] | Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway[J]. Journal of International Oncology, 2023, 50(8): 449-456. |
| [6] | Wu Jiali, Zhang Jiahui, Zhang Ping, Xiao Xinyue, Li Rui, Zhang Hongyu.Mechanism of Bcl-2 BH4 selective inhibitor BDA-366 on NK/T cell lymphoma cells[J]. Journal of International Oncology, 2023, 50(7): 413-418. |
| [7] | Yang Ya, Wang Huili, Liu Yan, Guo Jinfeng, Wang Chunxia, Lyu Min, Shan Changping.Effects of GCSH gene on proliferation and apoptosis of gastric cancer SNU-1 cells[J]. Journal of International Oncology, 2023, 50(5): 257-262. |
| [8] | Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207. |
| [9] | Zhu Yi, Chen Jian.Mechanism of hydrogen sulfide in tumorigenesis and development and its donor-mediated anti-tumor effects[J]. Journal of International Oncology, 2023, 50(12): 729-733. |
| [10] | Lian Haiwei, Yang Shuorui, Liu Renzhong.Mechanism study on regulation of glioblastoma cell proliferation and apoptosis by sciadopitysin combined with CX-4945 through Notch1 pathway[J]. Journal of International Oncology, 2022, 49(6): 321-326. |
| [11] | Xiao Nan, Sun Pengfei.Research progress of oxidative stress in the sensitivity of chemoradiotherapy for gliomas[J]. Journal of International Oncology, 2022, 49(6): 357-361. |
| [12] | Yang Ya, Ning Xiaofei, Li Bingliang, Yao Hui, Shan Changping, Lyu Min.Study on the mechanism of procyanidin mediated anti gastric cancer SNU-1 cell line by inducing the production of reactive oxygen species[J]. Journal of International Oncology, 2022, 49(5): 257-262. |
| [13] | Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2[J]. Journal of International Oncology, 2022, 49(4): 193-198. |
| [14] | Laibijiang Wusiman, Cao Bowei, Zhang Wenbin, Gao Hua.Effects of exogenous AGR2 on the proliferation and invasion abilities of colon cancer cells[J]. Journal of International Oncology, 2022, 49(2): 73-78. |
| [15] | Zhu Yishuo, Cui Yujie, Liu Qi, Li Jun, Fan Yuechao.Analysis of risk factors and prediction model establishment for early postoperative recurrence in glioma patients[J]. Journal of International Oncology, 2022, 49(2): 79-83. |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||